Cite
HARVARD Citation
Riva, N. et al. (2019). Safety and efficacy of nabiximols on spasticity symptoms in patients with motor neuron disease (CANALS): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial. Lancet neurology. 18 (2), pp. 155-164. [Online].